EGFR signaling networks in cancer therapy /

EGFR signaling networks in cancer therapy /

42

Bibliographic Details
Main Author:	Haley, John D
Format:
Language:	eng
Published:	New York : Humana Press, 2008
Subjects:	Cancer

Similar Items

Network quantification of EGFR signaling unveils potential for targeted combination therapy
by: Bertram Klinger, et al.
Published: (2013-01-01)

SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals
by: Kelin She, et al.
Published: (2019-04-01)

EGFR Targeted Nanocarriers for Cancer Diagnosis and Therapy
by: Azadeh Haeri, et al.
Published: (2017-01-01)

Targeting EGFR in Esophagogastric Cancer
by: Steven B. Maron, et al.
Published: (2020-12-01)

EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges
by: Balakarthikeyan Janani, et al.
Published: (2022-03-01)

IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer
by: Amy R. Leslie, et al.
Published: (2024-02-01)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
by: Zhe Zhang, et al.
Published: (2019-11-01)

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
by: Mary Luz Uribe, et al.
Published: (2021-06-01)

Improving Plasmonic Photothermal Therapy of Lung Cancer Cells with Anti-EGFR Targeted Gold Nanorods
by: Oscar Knights, et al.
Published: (2020-07-01)

Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
by: Fan Chen, et al.
Published: (2021-11-01)

Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru
by: Marco Galvez‐Nino, et al.
Published: (2023-01-01)

Emerging functions of the EGFR in cancer
by: Sara Sigismund, et al.
Published: (2018-01-01)

Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer Chemoresistance
by: Colleen M. Garvey, et al.
Published: (2020-05-01)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
by: Davide Ciardiello, et al.
Published: (2021-04-01)

Anti-EGFR conjugated nanoparticles to deliver Alpelisib as targeted therapy for head and neck cancer
by: Alberto Juan, et al.
Published: (2023-03-01)

Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer
by: Raghuveer Kavarthapu, et al.
Published: (2021-09-01)

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
by: Miren Taberna, et al.
Published: (2018-12-01)

Study of EGFR expression in tumor tissue in patients with locally advanced oral cavity cancer receiving cetuximab therapy
by: A. A. Lyanova, et al.
Published: (2020-07-01)

Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK
by: Sacha I. Rothschild
Published: (2015-05-01)

RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer
by: Marzia Di Donato, et al.
Published: (2023-10-01)

Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
by: Wang Fen, et al.
Published: (2012-08-01)

Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis
by: Suresh Chava, et al.
Published: (2022-05-01)

Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis
by: Yasmin A. Kadry, et al.
Published: (2021-10-01)

EGFR targeted therapy in lung cancer; an evolving story
by: C. Bartholomew, et al.
Published: (2017-01-01)

Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
by: Andreea Crintea, et al.
Published: (2023-09-01)

Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling
by: Lanming Cheng, et al.
Published: (2020-06-01)

Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer
by: Yuning Liao, et al.
Published: (2019-04-01)

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition.
by: Alessandro eOttaiano, et al.
Published: (2013-01-01)

Fibromodulin overexpression drives oral squamous cell carcinoma via activating downstream EGFR signaling
by: Lingyun Xia, et al.
Published: (2023-11-01)

RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR
by: Xing Wan, et al.
Published: (2020-01-01)

LINC00152 knock-down suppresses esophageal cancer by EGFR signaling pathway
by: Ding Yan, et al.
Published: (2020-03-01)

EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
by: Song X, et al.
Published: (2020-01-01)

Dual targeting of EGFR and glutaminase in lung cancer
by: Milica Momcilovic, et al.
Published: (2018-05-01)

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy
by: Wiebke Sihver, et al.
Published: (2014-03-01)

Effects of Annona muricata Extract on Triple-Negative Breast Cancer Cells Mediated Through EGFR Signaling
by: Alshaeri HK, et al.
Published: (2020-12-01)

Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway
by: Ling Li, et al.
Published: (2020-09-01)

Hippo in Gastric Cancer: From Signalling to Therapy
by: Lornella Seeneevassen, et al.
Published: (2022-05-01)

Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells
by: Sukanya Unson, et al.
Published: (2022-07-01)

Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review
by: Yue I. Cheng, et al.
Published: (2019-11-01)

The Silkworm Carboxypeptidase Inhibitor Prevents Gastric Cancer Cells’ Proliferation through the EGF/EGFR Signaling Pathway
by: Junhong Ye, et al.
Published: (2023-01-01)